Wordt geladen...
Naproxen in rheumatoid arthritis. Extended trial.
121 patients with active rheumatoid arthritis, 91 of whom had proved intolerant of other nonsteroidal anti-inflammatory agents, were treated for a mean of 10 months with naproxen. A dosage of 250 mg twice daily produced sustained improvement in most of the standard clinical measurements. 28 patients...
Bewaard in:
Hoofdauteurs: | , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
1976
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1006592/ https://ncbi.nlm.nih.gov/pubmed/795386 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|